Table 3.
High prevalence of metabolic syndrome in patients with rheumatic diseases
| Metabolic syndrome prevalence, percentage | |||||||
| Number | Mean age, years | Women, percentage | NCEP | WHO | NCEP | WHO | |
| Rheumatoid arthritis (RA) | Control | ||||||
| Karvounaris, et al. [62] | 200 | 63 | 74 | 44 | - | 41 | - |
| Chung, et al. [63] | |||||||
| Early RA | 88 | 51 | 64 | 30 | 31 | 22 | - |
| Established RA | 66 | 59 | 73 | 42 | 42 | ||
| Dessein, et al. [61] | 74 | 56 | 86 | - | 19 | - | - |
| Systemic lupus erythematosus | Control | ||||||
| Chung, et al. [67] | 102 | 40 | 91 | 29 | 32 | 20 | 11 |
| Magadmi, et al. [66] | 44 | 51 | 100 | 18 | - | - | - |
| Ankylosing spondylitis | Control | ||||||
| Malesci, et al. [68] | 24 | 51 | 12 | 46 | - | 11 | - |
NCEP, National Cholesterol Education Program; WHO, World Health Organization.